Amneal Pharmaceuticals, Inc.
AMRX· Nasdaq
AMRXAmneal Pharmaceuticals, Inc.
Filed Aug 9, 2018 · 10-Q · 40 days after period end · 0001723128-18-000030
| Metric | Q2 2018 | Q2 2017 |
|---|---|---|
| Revenue | $413.79M | $259.87M |
| Net Income | -$17.86M | $0.00 |
| EPS Diluted | -$0.15 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amneal Pharmaceuticals, Inc. · CIK 1723128 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 9, 2018 · 40 d after period end
